Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003157
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach

Who this might be right for
Gastric CancerPancreatic Cancer
Alliance for Clinical Trials in Oncology 26
Not applicableStudy completedNCT02981719
What this trial is testing

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 61
Testing effectiveness (Phase 2)Study completedNCT02648282
What this trial is testing

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Testing effectiveness (Phase 2)Study completedNCT00376948
What this trial is testing

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Study completedNCT00063947
What this trial is testing

Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+1 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT01430052
What this trial is testing

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases 110
Early research (Phase 1)UnknownNCT02024633
What this trial is testing

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03910387
What this trial is testing

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Who this might be right for
Locally Advanced Unresectable Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic Adenocarcinoma+2 more
Emory University 23
Testing effectiveness (Phase 2)Ended earlyNCT03736720
What this trial is testing

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Who this might be right for
Locally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine Carcinoma+5 more
Roswell Park Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT01251640
What this trial is testing

Combination With Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Bayer 90
Not applicableStudy completedNCT03257150
What this trial is testing

The Use of Irreversible Electroporation in Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
University Health Network, Toronto 12
Very early researchLooking for participantsNCT07089940
What this trial is testing

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
OHSU Knight Cancer Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT05861336
What this trial is testing

GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Not applicableUnknownNCT02416609
What this trial is testing

Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Modena 44
Testing effectiveness (Phase 2)Study completedNCT03158779
What this trial is testing

Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 45
Early research (Phase 1)Study completedNCT00467116
What this trial is testing

PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca

Who this might be right for
Pancreatic Cancer
Vanderbilt-Ingram Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Temporarily pausedNCT05494697
What this trial is testing

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

Who this might be right for
Pancreatic Cancer
AIM ImmunoTech Inc. 90
Next Page